A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

NCT02515734 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: fluorouracil
DRUG: Leucovorin
DRUG: irinotecan
DRUG: oxaliplatin
BIOLOGICAL: bevacizumab
BIOLOGICAL: cetuximab

Sponsor

Japan Clinical Cancer Research Organization